# A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma

> **NCT00675649** · PHASE2 · WITHDRAWN · sponsor: **Centocor, Inc.**

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** CNTO 148 / Golimumab
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT00675649
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675649, "A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00675649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*